Yuehua Zhou

Medicine · Health Sciences

13h-index1.4kcitations41works0.92yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Effects of Radiation Exposure(11), Management of metastatic bone disease(10), Cancer Immunotherapy and Biomarkers(4), Immunotherapy and Immune Responses(4), Viral-associated cancers and disorders(4)

Publications41 total

[Expert consensus on evaluation index system construction for new traditional Chinese medicine(TCM) from TCM clinical practice in medical institutions].
PubMed·2025
Figure S3 from A Bifunctional Antibody Targeting PD-1 and TGF-β Signaling Has Antitumor Activity in Combination with Radiotherapy and Attenuates Radiation-Induced Lung Injury
2025Open Access
Figure S2 from A Bifunctional Antibody Targeting PD-1 and TGF-β Signaling Has Antitumor Activity in Combination with Radiotherapy and Attenuates Radiation-Induced Lung Injury
2025Open Access
Figure S7 from A Bifunctional Antibody Targeting PD-1 and TGF-β Signaling Has Antitumor Activity in Combination with Radiotherapy and Attenuates Radiation-Induced Lung Injury
2025Open Access
Figure S1 from A Bifunctional Antibody Targeting PD-1 and TGF-β Signaling Has Antitumor Activity in Combination with Radiotherapy and Attenuates Radiation-Induced Lung Injury
2025Open Access
Figure S5 from A Bifunctional Antibody Targeting PD-1 and TGF-β Signaling Has Antitumor Activity in Combination with Radiotherapy and Attenuates Radiation-Induced Lung Injury
2025Open Access
Data from A Bifunctional Antibody Targeting PD-1 and TGF-β Signaling Has Antitumor Activity in Combination with Radiotherapy and Attenuates Radiation-Induced Lung Injury
2025Open Access
Figure S8 from A Bifunctional Antibody Targeting PD-1 and TGF-β Signaling Has Antitumor Activity in Combination with Radiotherapy and Attenuates Radiation-Induced Lung Injury
2025Open Access
Figure S6 from A Bifunctional Antibody Targeting PD-1 and TGF-β Signaling Has Antitumor Activity in Combination with Radiotherapy and Attenuates Radiation-Induced Lung Injury
2025Open Access
Figure S4 from A Bifunctional Antibody Targeting PD-1 and TGF-β Signaling Has Antitumor Activity in Combination with Radiotherapy and Attenuates Radiation-Induced Lung Injury
2025Open Access
Supplementary Table S1 from A Bifunctional Antibody Targeting PD-1 and TGF-β Signaling Has Antitumor Activity in Combination with Radiotherapy and Attenuates Radiation-Induced Lung Injury
2025Open Access
A Bifunctional Antibody Targeting PD-1 and TGF-β Signaling Has Antitumor Activity in Combination with Radiotherapy and Attenuates Radiation-Induced Lung Injury
Cancer Immunology Research·2025· 5 citedOpen Access
Construction and Expression of Fc-FGF21 by Different Expression Systems and Comparison of Their Similarity and Difference with Efruxifermin by In Vitro and In Vivo Studies
Applied Biochemistry and Biotechnology·2024· 1 citedOpen Access
Multifunctional nanoparticles potentiate in-situ tumor vaccines via reversing insufficient Photothermal therapy by disrupting tumor vasculature
Journal of Controlled Release·2024· 6 cited
[Varieties systematization and standards status analysis of fermented Chinese medicine].
PubMed·2023· 2 cited
Characterization of the high-affinity anti-CTLA-4 monoclonal antibody JS007 for immune checkpoint therapy of cancer
mAbs·2022· 4 citedOpen Access
[Reflections on supervision strategies of new Tibetan drug registration].
PubMed·2022
[Thoughts on path of R&D and registration of innovative traditional Chinese medicine with synchronous transformation of "series prescriptions"].
PubMed·2022
Identification of a hotspot on PD-L1 for pH-dependent binding by monoclonal antibodies for tumor therapy
Signal Transduction and Targeted Therapy·2020· 13 citedOpen Access
Glycosylation-independent binding of monoclonal antibody toripalimab to FG loop of PD-1 for tumor immune checkpoint therapy.
PubMed·2020· 65 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Sheng Wang(11), Duo Xu(11), Yuan Wang(11), Lingyan Xiao(11), Jingyao Tu(11), Wan Qin(11), Sidan Tian(11), Bolong Zheng(11), Yihua Wang(11), Xianglin Yuan(11), Yuanhui Liu(11), Bo Liu(11), Da‐Jin Li(4), L. Jeffrey Medeiros(4), Fang Li(4), Lisa Thomas(3), Bing Hu(3), Moshe Arditi(3), María T. Abreu(3), Xiao‐Yong Zhu(3)